FDA’s Sentinel Framework Should Preclude “Unbridled” Data Mining – Platt

FDA's nascent electronic post-market drug safety monitoring project - Sentinel - should be designed to investigate only known problems or specific issues raised by spontaneous reports or studies, Harvard University's Richard Platt recommends